BR9814499A - Peptìdeo amida opióide sintético ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, processo para tratamento compreendendo a administração de uma quantidade da mesma - Google Patents
Peptìdeo amida opióide sintético ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, processo para tratamento compreendendo a administração de uma quantidade da mesmaInfo
- Publication number
- BR9814499A BR9814499A BR9814499-5A BR9814499A BR9814499A BR 9814499 A BR9814499 A BR 9814499A BR 9814499 A BR9814499 A BR 9814499A BR 9814499 A BR9814499 A BR 9814499A
- Authority
- BR
- Brazil
- Prior art keywords
- phe
- nle
- arg
- morpholinyl
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"PEPTìDEO AMIDA OPIóIDE SINTéTICO OU UM SAL FARMACEUTICAMENTE ACEITáVEL DO MESMO, COMPOSIçãO FARMACêUTICA, E, PROCESSO PARA TRATAMENTO COMPREENDENDO A ADMINISTRAçãO DE UMA QUANTIDADE DA MESMA". Peptídeos que demonstram alta seletividade para o receptor opióide kappa (KOR) e longa duração de ação periférica sem entrada significante no cerébro são criados que são seq³ências de quatro resíduos de aminoácidos D-isómero tendo um C-término que é uma amida mono- ou disubstituída. Os compostos representativos, que tem uma afinidade para o KOR de pelo menos 1000 vezes sua afinidade para o receptor opióide mu e um ED~ 50~ não maior que cerca de 0,5 mg/kg, incluem H-D-Phe-D-Phe-D-Nle-D-Arg-NHEt, H-D-Phe-D-Phe-D-Nle-D-Arg-morfolinila, H-D-Phe-D-Phe-D-Nle-D-Arg-Nh-4-picolila, H-D-Phe-D-Phe-D-Nle-D-Arg-NHPr,H-D-Phe-D-Phe-D-Nle-D-Arg-tio morfolinila, H-D-Phe-D-Phe-D-Nle-D-Arg-Net~ 2~, H-D-Phe-D-Phe-D-Nle-D-Arg-NHMe, H-D-Phe-D-Phe-D-Nle-D-Orn-morfolinila, H-D-4Fpa-D-Phe-D-Nle-D-Arg-NH-4-picolila, H-D-Phe-D-Phe-D-Nle-D-Arg-NH-ciclopropila, H-D-Ala(2Thi)D-3,4-Cpa-D-Leu-D-Arg-morfolinila, H-D-Phe-D-Phe-D-Nle-D-Gmf-morfolinila, H-D-Phe-D-Phe-D-Leu-D-Orn-NH (Aeb), H-D-Phe-D-Phe-D-Leu-D-Lys-morfolinila, H-D-Phe-D-Phe-D-Nle-D-Arg-piperazinila, e H-D-Phe-D-Phe-D-Nle-D-Arg-NH(Hoh).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/997208 | 1997-12-23 | ||
| US08/997,208 US5965701A (en) | 1997-12-23 | 1997-12-23 | Kappa receptor opioid peptides |
| PCT/US1998/027282 WO1999032510A1 (en) | 1997-12-23 | 1998-12-22 | Kappa receptor opioid peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR9814499A true BR9814499A (pt) | 2000-10-10 |
| BR9814499B1 BR9814499B1 (pt) | 2014-10-21 |
Family
ID=25543752
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9814499A BRPI9814499B8 (pt) | 1997-12-23 | 1998-12-22 | Peptídeo amida opióide sintético ou um sal farmaceuticamente aceitavel do mesmo, e, composição farmacêutica |
| BRPI9814499-5A BR9814499B1 (pt) | 1997-12-23 | 1998-12-22 | Peptídeo amida opióide sintético ou um sal farmaceuticamente aceitavel do mesmo, e, composição farmacêutica |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9814499A BRPI9814499B8 (pt) | 1997-12-23 | 1998-12-22 | Peptídeo amida opióide sintético ou um sal farmaceuticamente aceitavel do mesmo, e, composição farmacêutica |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US5965701A (pt) |
| EP (1) | EP1042359B1 (pt) |
| JP (1) | JP4275852B2 (pt) |
| KR (1) | KR100629548B1 (pt) |
| CN (1) | CN1154655C (pt) |
| AR (1) | AR014167A1 (pt) |
| AT (1) | ATE301670T1 (pt) |
| AU (1) | AU747806B2 (pt) |
| BR (2) | BRPI9814499B8 (pt) |
| CA (1) | CA2315878C (pt) |
| CR (1) | CR5936A (pt) |
| CZ (1) | CZ297281B6 (pt) |
| DE (1) | DE69831176T2 (pt) |
| DK (1) | DK1042359T3 (pt) |
| EE (1) | EE04440B1 (pt) |
| ES (1) | ES2247735T3 (pt) |
| HR (1) | HRP20000415B1 (pt) |
| HU (1) | HU227640B1 (pt) |
| IL (3) | IL136742A0 (pt) |
| MY (1) | MY117542A (pt) |
| NO (1) | NO327080B1 (pt) |
| NZ (1) | NZ505183A (pt) |
| PL (1) | PL195842B1 (pt) |
| PT (1) | PT1042359E (pt) |
| RU (1) | RU2217437C2 (pt) |
| SK (1) | SK286135B6 (pt) |
| TR (1) | TR200001985T2 (pt) |
| TW (1) | TW580502B (pt) |
| UA (1) | UA68366C2 (pt) |
| UY (1) | UY25327A1 (pt) |
| WO (1) | WO1999032510A1 (pt) |
| ZA (1) | ZA9811801B (pt) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| AU1623801A (en) * | 1999-11-19 | 2001-05-30 | Palatin Technologies, Inc. | Opioid metallopeptide compositions and methods |
| DE10116978A1 (de) * | 2001-04-05 | 2002-10-10 | Merck Patent Gmbh | Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase |
| JP4239592B2 (ja) * | 2001-05-08 | 2009-03-18 | 東レ株式会社 | 敗血症治療剤 |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| MX373000B (es) | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| EP2040733A2 (en) * | 2006-05-26 | 2009-04-01 | Cara Therapeutics, Inc. | Method for elevating prolactin in mammals |
| CN101454338A (zh) * | 2006-05-26 | 2009-06-10 | 卡拉治疗学股份有限公司 | κ阿片样受体肽的N-氧化物 |
| US8236766B2 (en) * | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
| JP5244810B2 (ja) | 2006-11-10 | 2013-07-24 | カラ セラピューティクス インコーポレイテッド | 合成ペプチドアミド |
| US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
| US8906859B2 (en) * | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
| US7713937B2 (en) * | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
| WO2008077194A1 (en) * | 2006-12-22 | 2008-07-03 | Xenome Ltd | Receptor agonists |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| MX373659B (es) * | 2014-06-26 | 2020-03-31 | Maruishi Pharma | Metodo para producir un pentapeptido sintetico. |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| WO2016181408A2 (en) | 2015-05-11 | 2016-11-17 | Cadila Healthcare Limited | NOVEL SHORT-CHAIN PEPTIDES AS KAPPA (κ) OPIOID RECEPTORS (KOR) AGONIST |
| CN107098876B (zh) * | 2016-02-23 | 2021-04-06 | 江苏恒瑞医药股份有限公司 | 苯基丙酰胺类衍生物、其制备方法及其在医药上的应用 |
| CN109563133B (zh) * | 2016-09-27 | 2020-09-11 | 四川科伦博泰生物医药股份有限公司 | 多酰胺化合物及其用途 |
| BR112020001157A2 (pt) * | 2017-07-21 | 2020-07-21 | Sichuan Haisco Pharmaceutical Co., Ltd. | compostos de peptídeo amida, método de preparação dos mesmos e uso em medicina |
| CN111065631B (zh) | 2017-12-06 | 2021-10-08 | 江苏恒瑞医药股份有限公司 | 一种苯基丙酰胺类衍生物的盐及其制备方法 |
| US20210205404A1 (en) | 2018-05-16 | 2021-07-08 | Jiangsu Hengrui Medicine Co., Ltd. | Pharmaceutical composition of kor receptor agonist |
| CN114127086B (zh) * | 2019-07-25 | 2023-10-20 | 四川海思科制药有限公司 | 氘代肽酰胺类化合物及其制备方法和在医药上的用途 |
| CN114127085B (zh) * | 2019-07-25 | 2024-08-13 | 西藏海思科制药有限公司 | 一种肽酰胺盐及其制备方法和在医药上的用途 |
| CN114615976A (zh) * | 2019-08-07 | 2022-06-10 | 人福医药美国公司 | κ阿片受体肽酰胺激动剂 |
| US12616732B2 (en) | 2020-06-25 | 2026-05-05 | Yichang Humanwell Pharmaceuticals Co., Ltd. | Peptides for treatment of medical disorders |
| JP7577265B2 (ja) | 2020-06-25 | 2024-11-05 | ヒューマンウェル ファーマシューティカル ユーエス，インコーポレイテッド | 医学的障害の治療のためのペプチド |
| US20240336565A1 (en) | 2021-07-02 | 2024-10-10 | Acer Therapeutics, Inc. | Solid forms of osanetant |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2013689B (en) * | 1977-12-15 | 1982-03-24 | Reckitt & Colmann Prod Ltd | Compounds |
| GB8801304D0 (en) * | 1988-01-21 | 1988-02-17 | Ici Plc | Diamine compounds |
| US5367053A (en) * | 1993-05-19 | 1994-11-22 | Houghten Pharmaceuticals, Inc. | Opioid peptide inhibitors |
| RU2067000C1 (ru) * | 1994-06-29 | 1996-09-27 | Владислав Исакович Дейгин | Пептид и способ его получения |
| US5610271A (en) * | 1995-06-07 | 1997-03-11 | Torrey Pines Institute For Molecular Studies | Kappa receptor selective opioid peptides |
-
1997
- 1997-12-23 US US08/997,208 patent/US5965701A/en not_active Expired - Lifetime
-
1998
- 1998-12-22 HU HU0100626A patent/HU227640B1/hu not_active IP Right Cessation
- 1998-12-22 BR BRPI9814499A patent/BRPI9814499B8/pt unknown
- 1998-12-22 CZ CZ20002382A patent/CZ297281B6/cs not_active IP Right Cessation
- 1998-12-22 AT AT98964224T patent/ATE301670T1/de active
- 1998-12-22 UA UA2000063810A patent/UA68366C2/uk unknown
- 1998-12-22 NZ NZ505183A patent/NZ505183A/en not_active IP Right Cessation
- 1998-12-22 BR BRPI9814499-5A patent/BR9814499B1/pt not_active IP Right Cessation
- 1998-12-22 ZA ZA9811801A patent/ZA9811801B/xx unknown
- 1998-12-22 EE EEP200000370A patent/EE04440B1/xx not_active IP Right Cessation
- 1998-12-22 KR KR1020007006936A patent/KR100629548B1/ko not_active Expired - Lifetime
- 1998-12-22 EP EP98964224A patent/EP1042359B1/en not_active Expired - Lifetime
- 1998-12-22 DE DE69831176T patent/DE69831176T2/de not_active Expired - Lifetime
- 1998-12-22 HR HR20000415A patent/HRP20000415B1/xx not_active IP Right Cessation
- 1998-12-22 TR TR2000/01985T patent/TR200001985T2/xx unknown
- 1998-12-22 PT PT98964224T patent/PT1042359E/pt unknown
- 1998-12-22 CA CA2315878A patent/CA2315878C/en not_active Expired - Lifetime
- 1998-12-22 RU RU2000119773/04A patent/RU2217437C2/ru active
- 1998-12-22 MY MYPI98005818A patent/MY117542A/en unknown
- 1998-12-22 PL PL98341308A patent/PL195842B1/pl not_active IP Right Cessation
- 1998-12-22 WO PCT/US1998/027282 patent/WO1999032510A1/en not_active Ceased
- 1998-12-22 IL IL13674298A patent/IL136742A0/xx active IP Right Grant
- 1998-12-22 ES ES98964224T patent/ES2247735T3/es not_active Expired - Lifetime
- 1998-12-22 CR CR5936A patent/CR5936A/es unknown
- 1998-12-22 DK DK98964224T patent/DK1042359T3/da active
- 1998-12-22 JP JP2000525447A patent/JP4275852B2/ja not_active Expired - Lifetime
- 1998-12-22 CN CNB98812582XA patent/CN1154655C/zh not_active Expired - Lifetime
- 1998-12-22 AU AU19402/99A patent/AU747806B2/en not_active Ceased
- 1998-12-22 SK SK960-2000A patent/SK286135B6/sk not_active IP Right Cessation
- 1998-12-23 UY UY25327A patent/UY25327A1/es unknown
- 1998-12-23 AR ARP980106652A patent/AR014167A1/es active IP Right Grant
-
1999
- 1999-02-10 TW TW087121390A patent/TW580502B/zh not_active IP Right Cessation
-
2000
- 2000-06-12 IL IL136742A patent/IL136742A/en not_active IP Right Cessation
- 2000-06-21 NO NO20003245A patent/NO327080B1/no not_active IP Right Cessation
-
2006
- 2006-10-05 IL IL178471A patent/IL178471A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI9814499B8 (pt) | Peptídeo amida opióide sintético ou um sal farmaceuticamente aceitavel do mesmo, e, composição farmacêutica | |
| Veber et al. | The design of metabolically-stable peptide analogs | |
| JP3347332B2 (ja) | インダノンによる２６ｓおよび２０ｓプロテアソームの抑制 | |
| HUP0000492A1 (hu) | N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával | |
| ATE384077T1 (de) | Stereoselektive antifibrillogene peptide | |
| US10179803B2 (en) | Methods for inhibiting immune complex formation in a subject | |
| CA2550085A1 (en) | Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders | |
| WO2002005748A3 (en) | Medicinal uses of mu-opioid receptor agonists | |
| MX9703642A (es) | Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana. | |
| BR0213291A (pt) | Composição e método para tratamento de diabetes | |
| US6916904B2 (en) | Inhibition of immune complex formation | |
| EP0831878A1 (en) | Novel peptide inhibitors of calmodulin | |
| HUT65465A (en) | Process for producing the rapeutic peptides | |
| Hasenöhrl et al. | Evidence for dose-dependent positively and negatively reinforcing effects of the substance P C-terminal analog DIME-C7 | |
| RU2264823C2 (ru) | Способ и пептиды для лечения эректильной дисфункции, способ и фармацевтическая композиция с использованием указанных пептидов | |
| US20080200392A1 (en) | Methods for Treating Parkinson's Disease | |
| IL120503A0 (en) | Peptides for the treatment of systemic lupus erythematosis and pharmaceutical compositions containing them | |
| US7087575B2 (en) | Treating the effect of nicotine | |
| WO2007144979A1 (ja) | ペプチド誘導体 | |
| AU2011253771B2 (en) | Method for inhibiting immune complex formation in a subject | |
| NO921595L (no) | Superaktive grf analoger | |
| PT94923A (pt) | Processo de preparacao de analogos "pseudo" hexapeptidos, heptapeptidos, octapeptidos e nonapeptidos da lhrh e de composicoes farmaceuticas que os contem | |
| CA2216704A1 (en) | Novel peptides and remedy for bone diseases containing the same as active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: CARA THERAPEUTICS, INC. (US) Free format text: TRANSFERIDO DE: FERRING B.V. |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 37, INDEFIRO O PRESENTE PEDIDO, TENDO POR BASE OS ARTS. 13 E 8O DA LPI 9279 DE 14/05/96. |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/10/2014, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 22A ANUIDADE. |
|
| B24D | Patent annual fee: restoration after fee payment | ||
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 23A ANUIDADE. |
|
| B21H | Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2650 DE 19/10/2021 POR TER SIDO INDEVIDA. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2285 DE 21/10/2014. PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/12/1998, OBSERVADAS AS CONDICOESLEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |